CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $32,746,000 | -18.8% | 1,400,000 | 0.0% | 1.86% | -26.7% |
| Q4 2020 | $40,320,000 | +42.2% | 1,400,000 | 0.0% | 2.53% | -4.3% |
| Q3 2020 | $28,364,000 | -32.6% | 1,400,000 | 0.0% | 2.64% | -40.0% |
| Q2 2020 | $42,070,000 | -39.3% | 1,400,000 | -36.5% | 4.41% | -62.4% |
| Q1 2020 | $69,257,000 | -47.9% | 2,203,529 | -22.0% | 11.71% | -41.0% |
| Q4 2019 | $133,016,000 | – | 2,823,529 | – | 19.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |